Thessaloniki, Greece

Theodoros Panagiotidis

This inventor holds 1 USPTO granted patent and 4 published patent applications and 4 EPO patents. Top assignee: Pharmathen S.a.. Active years: 2014.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Theodoros Panagiotidis: Innovator in Pharmaceutical Chemistry

Introduction

Theodoros Panagiotidis is a notable inventor based in Salonika, Greece. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel processes for drug preparation. His work has implications for the production of important pharmaceutical compounds.

Latest Patents

Panagiotidis holds a patent for a process titled "Process for the preparation of O-desmethyl-venlafaxine and salts thereof." This invention relates to a novel method for preparing O-desmethyl venlafaxine (ODV) and its pharmaceutically acceptable salts. The process involves the provision of a spiro-venlafaxine compound as an intermediate, converting this intermediate into ODV free base in a one-pot process, and optionally converting the ODV free base into pharmaceutically acceptable salts. Additionally, the invention includes novel processes for preparing crystalline salts of ODV-succinate and ODV-oxalate. He has 1 patent to his name.

Career Highlights

Panagiotidis is associated with Pharmathen S.A., a company known for its focus on pharmaceutical development and manufacturing. His role at Pharmathen has allowed him to contribute to innovative solutions in drug formulation and production.

Collaborations

He has collaborated with notable colleagues such as Theoharis V Koftis and Ioanna Georgopoulou, enhancing the research and development efforts within his team.

Conclusion

Theodoros Panagiotidis exemplifies the spirit of innovation in pharmaceutical chemistry through his patented processes and collaborative efforts. His work continues to influence the field and contribute to advancements in drug preparation.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…